Outcomes of Liver Transplantation for Hepatocellular Carcinoma Beyond the University of California San Francisco Criteria: A Single-center ExperienceTRANSPLANTATIONIF52020-01-0124OAAI
Catheter-related vancomycin-resistant Enterococcus faecium bacteremia:: Clinical and molecular epidemiologyINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32016-06-2115PREAI
Efficacy and cost-effectiveness of voriconazole prophylaxis for prevention of invasive aspergillosis in high-risk liver transplant recipientsLIVER TRANSPLANTATIONIF3.92016-01-0828PREAI
LIVER TRANSPLANTATION FOR ACUTE HEPATIC DECOMPENSATION ACHIEVES EXCELLENT OUTCOMES WITHOUT INCREASED RECIDIVISM RATES: A SINGLE CENTER EXPERIENCEJOURNAL OF HEPATOLOGYIF332016-01-010PREAI
Clostridium difficile Infection in Liver Transplant RecipientsAMERICAN JOURNAL OF GASTROENTEROLOGYIF7.62015-10-010PRE
Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancerINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32015-01-0263PREAI
Central venous catheter-related bacteremia due to cram-negative bacilli: Significance of catheter removal in preventing relapseINFECTION CONTROL AND HOSPITAL EPIDEMIOLOGYIF32015-01-0282PREAI
Conventional TACE and Drug-Eluting Bead TACE as Locoregional Therapy Before Orthotopic Liver Transplantation: Comparison of Explant Pathologic ResponseTRANSPLANTATIONIF52014-10-1535OAAI
A Peak Inside the Share 35 Looking Glass: Characteristics and Outcomes From a Single CenterTRANSPLANTATIONIF52014-07-010PREAI
Functional Status After Liver Transplantation in Patients After Sharing MELD Scores ≥35.TRANSPLANTATIONIF52014-07-010PREAI
Outcomes of Large HCC Outside UCSF Criteria After Liver Transplantation.TRANSPLANTATIONIF52014-07-010PREAI
Combined Lung and Liver Transplantation: Analysis of a Single-Center ExperienceLIVER TRANSPLANTATIONIF3.92014-01-0151OAAI
Sinus Surgery Combined with Antifungal Therapy is Effective in the Treatment of Invasive Aspergillus Sinusitis in Neutropenic Patients with CancerINFECTIONIF3.62008-08-2521PREAI
Amphotericin B lipid complex versus liposomal amphotericin B monotherapy for invasive aspergillosis in patients with hematologic malignancyCANCERIF5.12008-01-2546OAAI
Novel antifungal agents as salvage therapy for invasive aspergillosis in patients with hematologic malignancies: posaconazole compared with high-dose lipid formulations of amphotericin B alone or in combination with caspofunginLEUKEMIAIF13.42007-12-2069PREAI
Colistin is effective in treatment of infections caused by multidrug-resistant Pseudomonas aeruginosa in cancer patientsANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52007-06-01125OAAI
Central venous catheter and Stenotrophomonas maltophilia bacteremia in cancer patientsCANCERIF5.12006-03-2469OAAI
Vancomycin-resistant Enterococcus faecium:: Catheter colonization, esp gene, and decreased susceptibility to antibiotics in biofilmANTIMICROBIAL AGENTS AND CHEMOTHERAPYIF4.52005-12-0158OAAI
Itraconazole added to a lipid formulation of amphotericin B does not improve outcome of primary treatment of invasive aspergillosisCANCERIF5.12005-04-2049OAAI
Impact of high-dose granulocyte transfusions in patients with cancer with candidemia - Retrospective case-control analysis of 491 episodes of candida species bloodstream infectionsCANCERIF5.12004-11-0493OAAI
个人简介
教育背景
工作经历
荣誉奖项
未登录.png){kind=icon}
未登录个人简介教育背景工作经历荣誉奖项
研究方向